Belgium's UCB is reportedly planning to divest UCB-Bioproducts, its peptides unit, to Solvay for about €100 million. UCB has declined to comment on the report, which appeared in the financial daily de Tijd.
- read this report from AFX
Belgium's UCB is reportedly planning to divest UCB-Bioproducts, its peptides unit, to Solvay for about €100 million. UCB has declined to comment on the report, which appeared in the financial daily de Tijd.
- read this report from AFX